Table 4 Multivariate analysis of overall survival and disease-free survival
Endpoints of the study | HR (95% CI) | P |
|---|---|---|
DFS | ||
Variables | ||
Type of conditioning | 1.391(0.537–3.600) | 0.497 |
Age of recipient | 0.982(0.898–1.073) | 0.685 |
Sex of recipient | 0.381(0.115–1.263) | 0.115 |
Disease status at BMT(CR1 vs ≥ CR2) | 3.670(1.500–8.978) | 0.004 |
Ph chromosome status | 1.303(0.387–4.379) | 0.669 |
Diagnosis to transplant lag | 0.961(0.902–1.002) | 0.064 |
OS | ||
Variables | ||
Conditioning (TBI/Cy vs Bu/cy) | 0.764(0.371–1.573) | 0.466 |
Age of recipient (≤30 vs ≥ 30) | 1.014(0.974–1.056) | 0.489 |
Sex of recipient (Female vs male) | 1.461(0.709–3.013) | 0.304 |
Disease status at BMT(CR1 vs ≥ CR2) | 1.660(0.813–3.390) | 0.164 |
Philadelphia chromosome status(Ph−ve vs Ph + ve) | 0.877(0.400–1.922) | 0.743 |
Diagnosis to transplant lag | 1.000(0.985–1.014) | 0.946 |